Pentobarbital

Revisión del 10:23 20 ene 2016 de Kshigyo (discusión | contribs.) (Pentobarbital page)
(difs.) ← Revisión anterior | Revisión actual (difs.) | Revisión siguiente → (difs.)

Administration

  • Type: Anticonvulsant, Barbiturate; Barbiturate
  • Routes of Administration: IV, IM
  • Common Trade Names: Nembutal

Adult Dosing

  • Procedural sedation: 150-200 mg IM x1
    • Onset 10-15min IM; duration 1-4h IM
  • Barbiturate coma: 1-3 mg/kg/h IV
    • Start: 10-15 mg/kg IV x1, then 1 mg/kg/h IV
    • Taper dose gradually to D/C if long-term use

Pediatric Dosing

  • Procedural sedation: 2-6 mg/kg IM x1
    • Max: 100 mg/dose
    • Onset: 10-15min IM, 1min IV; duration: 1-4h IM, 15min IV
  • Barbiturate coma: 1-3 mg/kg/h IV
    • Start: 10-15 mg/kg IV x1, then 1 mg/kg/h IV
    • Taper dose gradually to D/C if long-term use

Special Populations

  • Pregnancy Risk Factor: D

Renal Dosing

  • Renal impairment: decrease start dose

Hepatic Dosing

  • Hepatic impairment: decrease start dose

Contraindications

  • Allergy to class/drug
  • depressed respiratory fxn
  • porphyria
  • avoid abrupt withdrawal (long-term use)

Adverse Reactions

Serious

  • respiratory depression
  • Stevens-Johnson syndrome
  • angioedema
  • lupus erythematosus

Common

  • somnolence
  • agitation
  • confusion
  • hyperkinesia
  • ataxia
  • CNS depression

Pharmacology

  • Half-life: 15-50 hrs
  • Metabolism: CYP450
  • Excretion: Urine

Mechanism of Action

alters sensory cortex, cerebellar, and motor activities; produces sedation, hypnosis, and anesthesia

Comments

See Also

References

<Epocrates>